共 234 条
[1]
McKenna WJ(2017)Classification, epidemiology, and global burden of cardiomyopathies Circ Res 121 722-730
[2]
Maron BJ(2006)Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 1807-1816
[3]
Thiene G(2008)Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 270-276
[4]
Maron BJ(2016)Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy J Am Coll Cardiol 67 1399-1409
[5]
Towbin JA(2013)Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy JAMA 309 896-908
[6]
Thiene G(1993)Discordance in degree of right and left ventricular dilation in patients with dilated cardiomyopathy: recognition and clinical implications J Am Coll Cardiol 21 649-654
[7]
Antzelevitch C(2000)Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 1077-1084
[8]
Corrado D(2007)Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies Clin Cardiol 30 245-250
[9]
Arnett D(2013)Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy Eur J Heart Fail 15 660-670
[10]
Elliott P(2018)Reproducibility study on myocardial strain assessment using fast-SENC cardiac magnetic resonance imaging Sci Rep 8 14100-1149